Technology
Health
Biotechnology

MorphoSys

126

$25.26
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-1.21%) As of 1:40 PM EDT today
-$0.31 (-1.21%) Today

Why Robinhood?

You can buy or sell MorphoSys and other stocks, options, ETFs, and crypto commission-free!

About MOR

MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. Read More The Proprietary Development segment combines proprietary research and development of therapeutic compounds. The Partnered Discovery segment offers technologies to make human antibody-based therapeutics on behalf of partners in the pharmaceutical industry. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.

CEO
Jean-Paul Kress
Employees
426
Headquarters
Planegg, Bayern (Bavaria)
Founded
1992
Market Cap
3.19B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
130.60K
High Today
$25.26
Low Today
$24.40
Open Price
$24.50
Volume
64.35K
52 Week High
$37.96
52 Week Low
$18.21

Collections

Technology
Health
Biotechnology
Research And Development
Therapy
Pharmaceutical
2018 IPO
Europe (Non-UK)

MOR Earnings

-$1.76
-$0.81
$0.14
$1.09
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
— per share
Actual
-$1.76 per share
Replay Earnings Call

People Also Bought

Gilead Sciences

42,362

$75.71

+3.93%

Gilead Sciences

42,362

$75.71

+3.93%

Pfizer

51,048

$32.20

+4.21%

Bristol-Myers Squibb

10,012

$54.20

+2.68%

Sangamo Therapeutics

7,526

$6.45

+1.74%

You May Also Like

CBTX
FNX
GECCL
CSTR
NTSX
ASB-C
XONE
VOT
UGI
KMTUY
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy MOR

Market Price$25.26
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell MorphoSys stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up